Eventide Asset Management »

Nektar Therapeutics shares owned by Eventide Asset Management

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Eventide Asset Management from 13F filings

Historical chart of Eventide Asset Management investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Eventide Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $12M 9.4M 1.30
2024-06-30 $9.3M 7.5M 1.24

More positions owned by Eventide Asset Management

Trane Technologies SHS (TT)
D.R. Horton (DHI)
Old Dominion Freight Line (ODFL)
Roper Industries (ROP)
Waste Connections (WCN)
Mirum Pharmaceuticals (MIRM)
Mettler-Toledo International (MTD)
The Trade Desk Com Cl A (TTD)
Celldex Therapeutics Com New (CLDX)
Transmedics Group (TMDX)
Evolent Health Cl A (EVH)
Collegium Pharmaceutical Inc Common Stock Usd (COLL)
IDEXX Laboratories (IDXX)
Guardant Health (GH)
Rollins (ROL)

View all positions for Eventide Asset Management

Top funds holding Nektar Therapeutics

Deep Track Capital
BlackRock
BlackRock
Vanguard Group
Eventide Asset Management
Samlyn Capital
Citadel Advisors
PRIMECAP Management Company
Acadian Asset Management
Nantahala Capital Management
TCG Crossover Management
Geode Capital Management
Renaissance Technologies
State Street Corporation
Jacobs Levy Equity Management

View all funds holding Nektar Therapeutics